Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2009, p. 3582-3584, Vol. 53, No. 8
0066-4804/09/$08.00+0 doi:10.1128/AAC.01574-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae
Hong Bin Kim,1,2,3
Minghua Wang,3,4
Chi Hye Park,3
Eui-Chong Kim,5
George A. Jacoby,6 and
David C. Hooper3*
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea,1
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea,2
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts,3
Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China,4
Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea,5
Lahey Clinic, Burlington, Massachusetts6
Received 26 November 2008/
Returned for modification 26 December 2008/
Accepted 30 May 2009

ABSTRACT
The genes for multidrug efflux pump OqxAB, which is active on
fluoroquinolones, were found in human clinical isolates on a
plasmid in
Escherichia coli and on the chromosome of
Klebsiella pneumoniae. IS
26-like sequences flanked the plasmid-mediated
oqxAB genes, suggesting that they had been mobilized as part
of a composite transposon.

INTRODUCTION
Plasmid-borne genes conferring quinolone resistance have been
increasingly recognized (
7,
10). Recently a plasmid-encoded
efflux pump, OqxAB, conferring resistance to the quinoxaline-di-
N-oxide
olaquindox, which has been used as a growth promoter in pigs,
was discovered in
Escherichia coli isolates of porcine origin
in Denmark and Sweden (
4-
6). OqxAB was encoded by the genes
oqxA and
oqxB located on a 52-kb conjugative plasmid designated
pOLA52 and conferred resistance to multiple agents, including
fluoroquinolones (
4,
9). We have investigated the prevalence
of this plasmid-encoded multidrug efflux pump in clinical isolates
of
Enterobacteriaceae and have for the first time identified
an
oqxAB-encoding plasmid in an
E. coli isolate of human origin.
Isolates were from the collection of blood isolates from Seoul National University Hospital collected from 1998 to 2006. The same set of isolates was previously surveyed for other plasmid-mediated quinolone resistance (PMQR) genes (8). A total of 461 clinical isolates were screened by PCR for the oqxA gene. Isolates positive for oqxA were also tested for oqxB, and strains positive for both genes were confirmed by sequencing of the PCR products. The primers used are shown in Table 1.
One (0.4%) of 261
E. coli isolates, 3 (4.6%) of 65
Enterobacter cloacae isolates, and 100 (74.1%) of 135
Klebsiella pneumoniae isolates were provisionally classified as positive for both
oqxA and
oqxB. The
oqxAB-positive
E. coli was isolated from
the blood of a patient in 1999. A BLAST search of the nucleotide
sequence similarity of the
oqxB PCR products obtained from the
three
E. cloacae isolates gave identities of only 88% (399/453)
with pOLA52 (GenBank accession number EU370913) and 86% (394/454)
with the hydrophobe/amphiphile efflux-1 (HAE1) family transporter
of
Enterobacter sp. strain 638 (GenBank accession number CP000653).
There was, however, substantial similarity between the complete
nucleotide sequences of the tandem
oqxA and
oqxB genes from
E. coli 1-12 (GenBank accession number GQ120634; 99.5% and 99.0%,
respectively),
K. pneumoniae 4-39 (GenBank accession number
FJ975560; 98.2% and 99.0%, respectively), and
K. pneumoniae 5-80 (GenBank accession number FJ975561; 99.4% and 98.9%, respectively)
relative to those of pOLA52 and the chromosomal genes in
K. pneumoniae MGH78578 (GenBank accession number NC009648). Since
the
oqxAB genes appear to be chromosomal in
K. pneumoniae (
3,
9),
E. coli 1-12 was the most likely candidate to contain an
oqxAB- encoding plasmid (Table
2).
To test for the plasmid location of
oqxAB, plasmid DNAs were
obtained using a plasmid midi kit (Qiagen, Valencia, CA) and
hybridized with a horseradish peroxidase-labeled
oqxB probe
as previously described (
12). While the seven
E. coli strains,
one
E. cloacae strain, and one
K. pneumoniae strain tested all
contained one or more plasmids, only the plasmid from
E. coli 1-12 hybridized to the
oqxB probe, and this plasmid was estimated
to be more than 100 kb in size (Fig.
1) (Table
2). For
K. pneumoniae,
whole-cell DNA was also used for hybridization, and strong signals
were seen with bands comigrating with chromosomal DNA for all
four PCR-positive strains tested. Of the four repeatedly PCR-negative
K. pneumoniae strains (1-68, 2-54, 3-45, and 5-22) tested by
Southern hybridization, two had no signal with the
oqxB probe,
and two had a weak signal.
To determine whether the presence of
oqxAB genes was associated
with resistance to olaquindox, we determined MICs with olaquindox
(MP Biomedicals, Inc., Solon, OH) (
5) for nine
E. coli (including
oqxAB-positive strain 1-12), six
E. cloacae (three positive
and three negative for
oqxAB by PCR), and 10
K. pneumoniae (6
positive and 4 negative for
oqxAB) strains. In
E. coli and
E. cloacae strains and all but two
K. pneumoniae strains, the presence
of
oqxAB or related genes by PCR correlated with olaquindox
MICs of

128 µg/ml. Two
oqxAB-positive
K. pneumoniae strains,
however, had MICs of only 16 µg/ml (Table
2). Ciprofloxacin
MICs also varied among the tested strains. These strains lacked
other PMQR genes, with the exception of one strain positive
for
qepA and two positive for
aac(6'
)-Ib-cr.
E. coli 1-12 had
a ciprofloxacin MIC of >32 µg/ml, but four other
E. coli strains and one
K. pneumoniae strain negative for
oqxAB did as well, likely reflecting the presence of additional chromosomal
mutations. In
K. pneumoniae strains, the four strains with higher
olaquindox MICs had higher MICs of ciprofloxacin, but there
were no differences in the low MICs of ciprofloxacin for strains
of
E. cloacae that were positive and negative for
oqxAB by PCR.
To determine whether oqxAB was transferable from E. coli 1-12, conjugation experiments were carried out in Luria-Bertani (LB) broth or on filters with azide-resistant (Azr) E. coli J53 as the recipient at 37°C (12). Transconjugants were selected on LB agar plates containing ampicillin (100 µg/ml), chloramphenicol (25 or 50 µg/ml), olaquindox (32 or 64 µg/ml), or trimethoprim (2 µg/ml), depending on the antibiogram of the donor strain, and sodium azide (100 µg/ml) for counterselection. In addition, plasmids isolated from E. coli 1-12 were transformed into electrocompetent E. coli DH10B and plated onto LB plates containing ampicillin, chloramphenicol, or olaquindox. Although resistance to ampicillin was transferred, no direct transfer or cotransfer of oqxAB was found by either conjugation or electroporation. This finding suggests that the oqxB-hybridizing plasmid was nonconjugative under these conditions. Similarly, the E. cloacae strains that were positive for oqxAB by PCR and the six K. pneumoniae oqxAB-positive strains yielded no transconjugants.
We sequenced flanking DNA and the entirety of oqxAB in E. coli 1-12 with a series of outward-facing primers, starting from both sides of each PCR product of oqxA and oqxB, using an inverse PCR strategy (11). We digested DNA with NcoI or NgoMIV (New England Biolabs, Ipswich, MA) and ligated the digested DNA with T4 DNA ligase (New England Biolabs, Ipswich, MA). We then performed inverse PCRs using the primers designed from both oqxA (5'-AACCTCGTCTCCCGTGAAGAGTGG and 5'-TGAACGCTCTCCACCGCTTCAA) and oqxB (5'-CAGCTCAACAATAAGGATGCGGTC and 5'-GGAGATCAGGAAATCGCTCTCCTG), using PCR conditions of 95°C for 10 min, followed by 30 cycles of 4°C for 1 min, 55°C for 2 min, and 72°C for 4 min, followed by a final extension at 72°C for 10 min. A 6,027-bp DNA segment containing the oqxAB genes was found to be flanked by IS26-like sequences and to match completely the sequence surrounding oqxAB in pOLA52 (9) (bases 46,312 to 51,602 and 1 to 736 [GenBank accession no. EU370913]). Thus, the oqxAB genes in E. coli 1-12 appear to be located on a composite transposon previously named Tn6010 (9).
Since the oqxAB-positive isolates of K. pneumoniae differed in their levels of resistance to olaquindox and ciprofloxacin, we compared the relative expression levels of the oqxAB genes in the four K. pneumoniae isolates without other PMQR genes. Each strain was grown in LB broth at 37°C, cells were collected at an optical density at 600 nm of
0.5 (after 2 to 2.5 h), and total RNA was isolated with an RNeasy mini kit (Qiagen, Valencia, CA). cDNA synthesis and quantitative PCR amplification were conducted as previously described (2). The relative levels of expression of the oqxAB genes correlated with the level of olaquindox resistance (Table 3), suggesting that different levels of chromosomal gene expression may account for the differences in resistance and may contribute in part to the elevated MICs of ciprofloxacin. No differences in the sequences 5' of oqxA were found between strains 4-39 and 5-80, which differed 20-fold in levels of oqxB transcripts. Thus, the increased expression of oqxB in the two strains appears not to be due to mutation in a putative promoter, but might relate to differences in other as-yet-undefined regulatory elements in these strains.
View this table:
[in this window]
[in a new window]
|
TABLE 3. Expression of the oqxB gene in K. pneumoniae strains with or without the olaquindox resistance phenotypea
|
This is the first report of the presence of an
oqxAB-containing
plasmid in a human isolate of
E. coli. Although transfer of
the plasmid was not successful, Southern blotting for
oqxB indicated
that these genes were located on a plasmid, rather than the
chromosome. Considering that the
oqxAB genes are chromosomally
located in
K. pneumoniae and highly prevalent in clinical isolates,
the plasmid containing
oqxAB seems to have arisen by capture
from the
K. pneumoniae genome, which may be a reservoir for
this antibiotic resistance determinant (
9). The natural function
of
oqxAB remains unknown.

ACKNOWLEDGMENTS
This work was supported in part by grants R01AI057576 (to D.C.H.)
and R01AI043312 (to G.A.J.) from the National Institute of Health,
U.S. Public Health Service.
We thank Que Chi Truong-Bolduc, Yanpeng Ding, and Debra M. Mills for technical advice.

FOOTNOTES
* Corresponding author. Mailing address: Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114-2696. Phone: (617) 726-3812. Fax: (617) 726-7416. E-mail:
dhooper{at}partners.org 
Published ahead of print on 15 June 2009. 

REFERENCES
1 - Beutin, L., Q. Kong, L. Feng, Q. Wang, G. Krause, L. Leomil, Q. Jin, and L. Wang. 2005. Development of PCR assays targeting the genes involved in synthesis and assembly of the new Escherichia coli O174 and O177 O antigens. J. Clin. Microbiol. 43:5143-5149.[Abstract/Free Full Text]
2 - Ding, Y., Y. Onodera, J. C. Lee, and D. C. Hooper. 2008. NorB, an efflux pump in Staphylococcus aureus MW2, contributes to bacterial fitness in abscesses. J. Bacteriol. 190:7123-7129.[Abstract/Free Full Text]
3 - Fouts, D. E., H. L. Tyler, R. T. DeBoy, S. Daugherty, Q. Ren, J. H. Badger, A. S. Durkin, H. Huot, S. Shrivastava, S. Kothari, R. J. Dodson, Y. Mohamoud, H. Khouri, L. F. W. Roesch, K. A. Krogfelt, C. Struve, E. W. Triplett, and B. A. Methé. 2008. Complete genome sequence of the N2-fixing broad host range endophyte Klebsiella pneumoniae 342 and virulence predictions verified in mice. PLoS Genet. 4:e1000141.[CrossRef][Medline]
4 - Hansen, L. H., L. B. Jensen, H. I. Sørensen, and S. J. Sørensen. 2007. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J. Antimicrob. Chemother. 60:145-147.[Abstract/Free Full Text]
5 - Hansen, L. H., E. Johannesen, M. Burmolle, A. H. Sørensen, and S. J. Sørensen. 2004. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob. Agents Chemother. 48:3332-3337.[Abstract/Free Full Text]
6 - Hansen, L. H., S. J. Sørensen, H. S. Jorgensen, and L. B. Jensen. 2005. The prevalence of the OqxAB multidrug efflux pump amongst olaquindox-resistant Escherichia coli in pigs. Microb. Drug Resist. 11:378-382.[CrossRef][Medline]
7 - Jacoby, G., V. Cattoir, D. Hooper, L. Martinez-Martinez, P. Nordmann, A. Pascual, L. Poirel, and M. Wang. 2008. qnr gene nomenclature. Antimicrob. Agents Chemother. 52:2297-2299.[Free Full Text]
8 - Kim, H. B., C. H. Park, C. J. Kim, E.-C. Kim, G. A. Jacoby, and D. C. Hooper. 2009. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob. Agents Chemother. 53:639-645.[Abstract/Free Full Text]
9 - Norman, A., L. H. Hansen, Q. She, and S. J. Sørensen. 2008. Nucleotide sequence of pOLA52: a conjugative IncX1 plasmid from Escherichia coli which enables biofilm formation and multidrug efflux. Plasmid 60:59-74.[CrossRef][Medline]
10 - Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.[CrossRef][Medline]
11 - Triglia, T., M. G. Peterson, and D. J. Kemp. 1988. A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences. Nucleic Acids Res. 16:8186.[Free Full Text]
12 - Wang, M., J. H. Tran, G. A. Jacoby, Y. Zhang, F. Wang, and D. C. Hooper. 2003. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47:2242-2248.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, August 2009, p. 3582-3584, Vol. 53, No. 8
0066-4804/09/$08.00+0 doi:10.1128/AAC.01574-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., Robicsek, A.
(2009). Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin. Microbiol. Rev.
22: 664-689
[Abstract]
[Full Text]